Frequency of the CCR5 gene 32-basepair deletion in Hispanic Mexicans

Clinical and Experimental Dermatology

Volumn 24, Issue 2, 1999, Pages 127-129

  Salas Alanis, J C ^a   Mellerio, J E ^b   Ashton, G H S ^b   McGrath, John A ^b,c  

^a Serv Med de la Univ A de N L   (Mexico)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ARTICLE; BASE PAIRING; DISEASE COURSE; ETHNIC GROUP; GENE DELETION; GENE FREQUENCY; GENE POOL; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HEALTH ECONOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR GENE;

ALLELES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HIV-1; HUMANS; MEXICAN AMERICANS; RECEPTORS, CCR5; SEQUENCE DELETION;

EID: 0032949924     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1999.00432.x     Document Type: Article

References (11)

1. 1 Raport CJ. Gosling J, Schweickart VL, et al. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR 5) for RANTES, MIP-1β. and MIP-1α. J Biol Chem 1996; 271: 17161-6.
2. 2 Dragic T, Litwin V, Allaway GP et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667-73.
3. 3 Ansari-Lari MA, Liu XM, Metzker ML et al. The extent of genetic variation in the CCR 5 gene. Nature Genet 1997; 16: 221-2.
4. 4 Samson M, Libert F, Doranz BJ et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR 5 chemokine receptor gene. Nature 1996; 382: 722-5.
5. 5 Cui Y. Hagan KW, Zhang S, Peltz SW. Identification and characterization of genes that are required for the accelerated deradation of mRNAs containing a premature translational termination codon. Genes Dev 1995; 9: 423-36.
6. 6 Liu R, Paxton WA, Choe S et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367-77.
7. 7 Biti R, French R, Young J et al. HIV-1 infection in an individual homozygous for the CCR 5 deletion allele. Nature Med 1997; 3: 252-3.
8. 8 Huang Y, Paxton WA, Wolinsky SM et al. The role of a mutant CCR 5 allele in HIV-1 transmission and disease progression. Nature Med 1996; 2: 1240-3.
9. 9 Arenza-Seisdedos F, Virilizier JL. Rousset D et al. HIV blocked by chemokine antagonist. Nature 1996; 383: 400.
10. 10 Martinson JJ, Chapman NH, Rees DC et al. Global distribution of the CCR 5 gene 32-basepair deletion. Nature Genet 1997; 16: 100-3.
11. 11 Stephens JC, Reich DE, Goldstein DB et al. Dating the origin of the CCR 5-delta 32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 1998; 62: 1507-15.